BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olivier C, Cohen R, Begué P, Floret D. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 2000;19:1015-7. [PMID: 11055609 DOI: 10.1097/00006454-200010000-00018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Raymond J, Bergeret M, Gendrel D. Impact de la résistance bactérienne sur les infections graves. Archives de Pédiatrie 2001;8:697-704. [DOI: 10.1016/s0929-693x(01)80184-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
2 Choi S, Chung J, Kim B, Kwak YG, Kim TH, Lee EJ, Choo EJ, Jeon M, Lee MS, Bae I, Lee S, Song EH, Jun J, Kim M, Kim S, Lee S, Kim YS, Woo JH, Choi S. Clinical implication of extended-spectrum cephalosporin nonsusceptibility in Streptococcus pneumoniae meningitis. Eur J Clin Microbiol Infect Dis 2012;31:3029-34. [DOI: 10.1007/s10096-012-1657-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Thabet F, Tilouche S, Tabarki B, Amri F, Guediche M, Sfar M, Harbi A, Yacoub M, Essoussi A. Mortalité par méningites à pneumocoque chez l'enfant. Facteurs pronostiques à propos d'une série de 73 observations. Archives de Pédiatrie 2007;14:334-7. [DOI: 10.1016/j.arcped.2006.11.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
4 Bingen E, Levy C, Varon E, Rocque F, Boucherat M, d’Athis P, Aujard Y, Cohen R; The Bacterial Meningitis Study Group. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis 2008;27:191-9. [DOI: 10.1007/s10096-007-0417-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
5 Bourrillon A, Bingen E. Stratégie thérapeutique des méningites à pneumocoque résistant à la pénicilline en pédiatrie. Médecine et Maladies Infectieuses 2002;32:55-60. [DOI: 10.1016/s0399-077x(02)80008-7] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
6 Floret D. Méningite à pneumocoque et résistance bactérienne. Archives de Pédiatrie 2002;9:1166-72. [DOI: 10.1016/s0929-693x(02)00078-7] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sarlangue J, Castella C, Lehours P. [First and second line antibiotic therapy for bacterial meningitis in infants and children]. Med Mal Infect 2009;39:521-30. [PMID: 19409744 DOI: 10.1016/j.medmal.2009.02.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Lamb HM, Ormrod D, Scott LJ, Figgitt DP. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections. Drugs 2002;62:1041-89. [PMID: 11985490 DOI: 10.2165/00003495-200262070-00005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
9 Falagas ME, Roussos N, Gkegkes ID, Rafailidis PI, Karageorgopoulos DE. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin Investig Drugs. 2009;18:921-944. [PMID: 19548851 DOI: 10.1517/13543780902967624] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
10 Bingen E. Place du pneumocoque en pathologie infectieuse pédiatrique. Pathologie Biologie 2002;50:374-9. [DOI: 10.1016/s0369-8114(02)00322-x] [Cited by in Crossref: 15] [Article Influence: 0.8] [Reference Citation Analysis]
11 Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev. 2007;20:391-408, table of contents. [PMID: 17630331 DOI: 10.1128/cmr.00047-06] [Cited by in Crossref: 325] [Cited by in F6Publishing: 137] [Article Influence: 21.7] [Reference Citation Analysis]
12 Feigin RD, Cutrer WB. BACTERIAL MENINGITIS BEYOND THE NEONATAL PERIOD. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Elsevier; 2009. pp. 439-71. [DOI: 10.1016/b978-1-4160-4044-6.50042-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 . Observatoire des méningites bactériennes de l'enfant en France. Archives de Pédiatrie 2008;15:S97-8. [DOI: 10.1016/s0929-693x(08)75490-3] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Mcintosh EDG. Treatment and prevention strategies to combat pediatric pneumococcal meningitis. Expert Review of Anti-infective Therapy 2014;3:739-50. [DOI: 10.1586/14787210.3.5.739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Levy C, de La Rocque F, Cohen R. Actualisation de l’épidémiologie des méningites bactériennes de l’enfant en France. Médecine et Maladies Infectieuses 2009;39:419-31. [DOI: 10.1016/j.medmal.2009.03.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
16 Floret D; Group de pathologie infectieuse pédiatrique, Groupe francophone de réanimation et d'urgence pédiatrique. [Pediatric deaths due to community-acquired bacterial infection. Survey of French pediatric intensive care units]. Arch Pediatr 2001;8 Suppl 4:705s-11s. [PMID: 11582916 DOI: 10.1016/s0929-693x(01)80185-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
17 Wasier A, Chevret L, Essouri S, Durand P, Chevret S, Devictor D. Pneumococcal meningitis in a pediatric intensive care unit: Prognostic factors in a series of 49 children: . Pediatric Critical Care Medicine 2005;6:568-72. [DOI: 10.1097/01.pcc.0000170611.85012.01] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
18 Hernstadt H, Cheung A, Hurem D, Vasilunas N, Phuong LK, Quinn P, Agrawal R, Daley AJ, Cole T, Gwee A. Changing Epidemiology and Predisposing Factors for Invasive Pneumococcal Disease at Two Australian Tertiary Hospitals. Pediatr Infect Dis J 2020;39:1-6. [PMID: 31815835 DOI: 10.1097/INF.0000000000002489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y. Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis. 2004;10:1125-1128. [PMID: 15207068 DOI: 10.3201/eid1006.020665] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 3.7] [Reference Citation Analysis]